| abstract |
The present invention relates to a compound of formula (I), wherein the substituents are described in claim 1. The compounds are glycine uptake such as psychosis, pain, neurodegenerative dysfunction in memory and learning, schizophrenia, dementia, and other diseases in which cognitive processes are impaired (such as attention deficit disorder or Alzheimer's disease) It can be used to treat diseases based on inhibitors. |